# FDA Inspection 652918 - Bristol-Myers Squibb Company - March 22, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/bristol-myers-squibb-company/f283fe7f-f953-4ce5-8d91-1fb5daf6c1ae/
Source feed: FDA_Inspections

> FDA Inspection 652918 for Bristol-Myers Squibb Company on March 22, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 652918
- Company Name: Bristol-Myers Squibb Company
- Inspection Date: 2010-03-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1299176 - 2025-12-12](https://www.globalkeysolutions.net/api/records/fda_inspections/bristol-myers-squibb-company/428980e9-b0e3-4002-b89c-01c05c2fd564/)
- [FDA Inspection 857661 - 2013-11-22](https://www.globalkeysolutions.net/api/records/fda_inspections/bristol-myers-squibb-company/e06fd2ee-9ade-45ed-981f-a871babc9ea0/)
- [FDA Inspection 547474 - 2008-11-20](https://www.globalkeysolutions.net/api/records/fda_inspections/bristol-myers-squibb-company/fa38d6fd-880e-4dc3-bfd8-cef8d0aa3237/)

Company: https://www.globalkeysolutions.net/companies/bristol-myers-squibb-company/485fabe1-4ba4-46ef-b997-6467e4c074a1

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c